Suchergebnisse - "van de Donk, Niels W C J"

PubPharm (215)

211

The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myeloma

enthalten in: Blood | 2004

von Lokhorst, H. | Wu, K. | Verdonck, L. | +5

212

Protein geranylgeranylation is critical for the regulation of survival and proliferation of lymphoma tumor cells

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2003

von van de Donk, N. | Schotte, D. | Kamphuis, M. | +4

213

Inhibition of protein geranylgeranylation induces apoptosis in myeloma plasma cells by reducing Mcl-1 protein levels

enthalten in: Blood | 2003

von van de Donk, N. | Kamphuis, M. | van Kessel, B. | +2

214

Continuous low-dose cyclophosphamide-prednisone is effective and well tolerated in patients with advanced multiple myeloma

enthalten in: Netherlands journal of medicine | 2001

von de Weerdt, O. | van de Donk, N. | Veth, G. | +3

215

A Rational Strategy for Reducing On-Target Off-Tumor Effects of CD38-Chimeric Antigen Receptors by Affinity Optimization

enthalten in: Molecular therapy

von Drent, E. | Themeli, M. | Poels, R. | +9

[1]
« Vorheriger
12
13
14
15
16
17
18
19
20
21
22